| Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation NA Menzies, T Cohen, HH Lin, M Murray, JA Salomon PLoS medicine 9 (11), e1001347, 2012 | 267 | 2012 |
| The costs and effectiveness of four HIV counseling and testing strategies in Uganda N Menzies, B Abang, R Wanyenze, F Nuwaha, B Mugisha, A Coutinho, ... Aids 23 (3), 395-401, 2009 | 246 | 2009 |
| Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical … JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ... The Lancet Global Health 2 (1), e23-e34, 2014 | 241 | 2014 |
| Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ... The Lancet Global Health 4 (11), e806-e815, 2016 | 189 | 2016 |
| Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness KL Grabbe, N Menzies, M Taegtmeyer, G Emukule, P Angala, I Mwega, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 54 (3), 317-323, 2010 | 159 | 2010 |
| The cost of providing comprehensive HIV treatment in PEPFAR-supported programs NA Menzies, AA Berruti, R Berzon, S Filler, R Ferris, TV Ellerbrock, ... Aids 25 (14), 1753-1760, 2011 | 151 | 2011 |
| Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions NA Menzies, E Wolf, D Connors, M Bellerose, AN Sbarra, T Cohen, ... The Lancet Infectious Diseases 18 (8), e228-e238, 2018 | 120 | 2018 |
| The use and misuse of mathematical modeling for infectious disease policymaking: lessons for the COVID-19 pandemic LP James, JA Salomon, CO Buckee, NA Menzies Medical Decision Making 41 (4), 379-385, 2021 | 110 | 2021 |
| Nowcasting by Bayesian Smoothing: A flexible, generalizable model for real-time epidemic tracking SF McGough, MA Johansson, M Lipsitch, NA Menzies PLoS computational biology 16 (4), e1007735, 2020 | 107 | 2020 |
| Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae NA Menzies, M Quaife, BW Allwood, AL Byrne, AK Coussens, AD Harries, ... The Lancet Global Health 9 (12), e1679-e1687, 2021 | 104 | 2021 |
| The importance of heterogeneity to the epidemiology of tuberculosis JM Trauer, PJ Dodd, MGM Gomes, GB Gomez, RMGJ Houben, ... Clinical infectious diseases 69 (1), 159-166, 2019 | 103 | 2019 |
| Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models NA Menzies, GB Gomez, F Bozzani, S Chatterjee, N Foster, IG Baena, ... The Lancet global health 4 (11), e816-e826, 2016 | 87 | 2016 |
| The determinants of HIV treatment costs in resource limited settings NA Menzies, AA Berruti, JM Blandford PloS one 7 (11), e48726, 2012 | 76 | 2012 |
| The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States VE Pitzer, M Chitwood, J Havumaki, NA Menzies, S Perniciaro, JL Warren, ... American Journal of Epidemiology 190 (9), 1908-1917, 2021 | 73 | 2021 |
| Bayesian methods for calibrating health policy models: a tutorial NA Menzies, DI Soeteman, A Pandya, JJ Kim Pharmacoeconomics 35 (6), 613-624, 2017 | 71 | 2017 |
| Prospects for tuberculosis elimination in the United States: results of a transmission dynamic model NA Menzies, T Cohen, AN Hill, R Yaesoubi, K Galer, E Wolf, SM Marks, ... American journal of epidemiology 187 (9), 2011-2020, 2018 | 66 | 2018 |
| Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models D Keebler, P Revill, S Braithwaite, A Phillips, N Blaser, A Borquez, ... The Lancet Global Health 2 (1), e35-e43, 2014 | 65 | 2014 |
| Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. M Quaife, RMGJ Houben, B Allwood, T Cohen, AK Coussens, AD Harries, ... The Lancet Respiratory Medicine 8 (4), 332-333, 2020 | 63 | 2020 |
| Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study S Verguet, C Riumallo-Herl, GB Gomez, NA Menzies, RMGJ Houben, ... The Lancet Global Health 5 (11), e1123-e1132, 2017 | 61 | 2017 |
| Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings PGT Cudahy, JR Andrews, A Bilinski, DW Dowdy, B Mathema, ... The Lancet Infectious Diseases 19 (3), e89-e95, 2019 | 57 | 2019 |
Ted CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health在 yale.edu 的电子邮件经过验证
